Morphine does not facilitate breast cancer progression in two preclinical mouse models for human invasive lobular and HER2⁺ breast cancer

Pain
Chris W DoornebalMarkus W Hollmann

Abstract

Morphine and other opioid analgesics are potent pain-relieving agents routinely used for pain management in patients with cancer. However, these drugs have recently been associated with a worse relapse-free survival in patients with surgical cancer, thus suggesting that morphine adversely affects cancer progression and relapse. In this study, we evaluated the impact of morphine on breast cancer progression, metastatic dissemination, and outgrowth of minimal residual disease. Using preclinical mouse models for metastatic invasive lobular and HER2 breast cancer, we show that analgesic doses of morphine do not affect mammary tumor growth, angiogenesis, and the composition of tumor-infiltrating immune cells. Our studies further demonstrate that morphine, administered in the presence or absence of surgery-induced tissue damage, neither facilitates de novo metastatic dissemination nor promotes outgrowth of minimal residual disease after surgery. Together, these findings indicate that opioid analgesics can be used safely for perioperative pain management in patients with cancer and emphasize that current standards of "good clinical practice" should be maintained.

References

May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R Maneckjee, J D Minna
Sep 1, 1994·Brain, Behavior, and Immunity·G G PageJ C Liebeskind
Mar 14, 2001·Drug and Alcohol Dependence·L McCarthyT J Rogers
Jul 24, 2001·Anesthesiology·S Bar-YosefS Ben-Eliyahu
Sep 10, 2004·American Journal of Therapeutics·Ricardo VallejoRamsun Benyamin
Aug 5, 2006·Breast Cancer Research : BCR·Anna Fantozzi, Gerhard Christofori
Sep 29, 2006·Anesthesiology·Aristomenis K ExadaktylosDaniel I Sessler
Mar 31, 2007·American Journal of Respiratory Cell and Molecular Biology·Patrick A SingletonJoe G N Garcia
Jun 26, 2007·Journal of Mammary Gland Biology and Neoplasia·Jos Jonkers, Patrick W B Derksen
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sabita RoyJosephine Martin
Apr 17, 2008·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Daniel I Sessler
Jun 25, 2008·The Journal of Experimental Medicine·Gerald WillimskyThomas Blankenstein
Jul 19, 2008·Anesthesia and Analgesia·Rose ChristophersonFrank E Johnson
Nov 8, 2008·The AAPS Journal·Emily O Dumas, Gary M Pollack
Nov 17, 2009·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Ban C H TsuiBrendan T Finucane
Jan 1, 2010·The American Journal of Pathology·Josephine L MartinSabita Roy
May 4, 2010·Anesthesia and Analgesia·Antje GottschalkMohamed Tiouririne
May 29, 2010·Anesthesiology·Antje GottschalkEdward C Nemergut
Jul 10, 2010·The American Journal of Pathology·Lisa KoodieSabita Roy
Dec 16, 2010·Anesthesia and Analgesia·Biji MathewPatrick A Singleton
Jan 27, 2011·Cancer Metastasis Reviews·Banafsheh AfsharimaniMarie-Odile Parat
Mar 31, 2011·BMJ : British Medical Journal·Paul S MylesUNKNOWN ANZCA Trials Group Investigators
Apr 12, 2011·The Journal of Pathology·Metamia CiampricottiKarin E de Visser
Sep 22, 2011·International Journal of Cancer. Journal International Du Cancer·Aniket N TavareDaqing Ma
Jul 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elad NeemanShamgar Ben-Eliyahu
Nov 16, 2012·Cancer Research·Chris W DoornebalKarin E de Visser
Jan 4, 2013·British Journal of Anaesthesia·A Heaney, D J Buggy
Jan 16, 2013·Nature Reviews. Clinical Oncology·Shalini Dalal, Eduardo Bruera

❮ Previous
Next ❯

Citations

Oct 30, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F JankuJ Moss
Sep 8, 2016·International Anesthesiology Clinics·Tobias PiegelerPhilipp Lirk
Nov 10, 2016·Anesthesia and Analgesia·Mir W SekandarzadMarkus W Hollmann
Jun 9, 2017·British Journal of Pharmacology·Jason W Boland, A Graham Pockley
Sep 14, 2018·Pain Management·Oscar Diaz-CambroneroJuan P Cata
Mar 1, 2019·European Journal of Anaesthesiology·Philipp Lirk, James P Rathmell
Jul 13, 2017·Current Opinion in Anaesthesiology·Mir W SekandarzadMarkus W Hollmann
Jul 1, 2017·Current Pain and Headache Reports·Mark R JonesRichard D Urman
Sep 21, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·David BrinkmanHenry P Redmond
Mar 7, 2021·Journal of Clinical Medicine·Sarah D MüllerTobias Piegeler
Apr 17, 2021·Oncology and Therapy·Jeremy WatsonOmar Viswanath
May 11, 2021·Frontiers in Oncology·Hao-Wen ZhangZhan-Guo Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

The American Journal of Hospice Care
A G Lipman
Journal of Oral Medicine
G T Terezhalmy, L A Rye
The Journal of Pharmacology and Experimental Therapeutics
J TELFORDA S KEATS
© 2022 Meta ULC. All rights reserved